{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:26Z","timestamp":1787500226737,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanxi Province Science and Technology Fund","award":["201903D321130"],"award-info":[{"award-number":["201903D321130"]}]},{"name":"Overseas returnees start-up research fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several studies have confirmed that mobilizing bone marrow-derived stem cells (BMSCs) ameliorates renal function loss following cisplatin-induced acute kidney injury (AKI). The aim of this study was to explore whether the combination of granulocyte-colony stimulating factor (G-CSF) and plerixafor (AMD3100) exerts beneficial effects on renal function recovery in a model of cisplatin-induced nephrotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>C57BL\/6J mice received intraperitoneal injections of G-CSF (200\u2009\u03bcg\/kg\/day) for 5 consecutive days. On the day of the last injection, the mice received a single subcutaneous dose of AMD3100 (5\u2009mg\/kg) 1\u2009h before cisplatin 20\u2009mg\/kg injection. Ninety-six hours after cisplatin injection, the mice were euthanized, and blood and tissue samples were collected to assess renal function and tissue damage. Cell mobilization was assessed by flow cytometry (FCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mice pretreated with G-CSF\/AMD3100 exhibited longer survival and lower serum creatinine and blood urea nitrogen (BUN) levels than mice treated with only G-CSF or saline. Combinatorial G-CSF\/AMD3100 treatment attenuated tissue injury and cell death, enhanced cell regeneration, and mobilized a higher number of stem cells in the peripheral blood than G-CSF or saline treatment. Furthermore, the mRNA expression of proinflammatory factors was lower, whereas that of anti-inflammatory factors was higher, in the G-CSF\/AMD3100 group than in the G-CSF or saline group (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that combinatorial G-CSF\/AMD3100 therapy mobilizes BMSCs to accelerate improvements in renal functions and prevent cisplatin-induced renal tubular injury. This combinatorial therapy may represent a new therapeutic option for the treatment of AKI and should be further investigated in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02268-y","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T16:07:57Z","timestamp":1616602077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice"],"prefix":"10.1186","volume":"12","author":[{"given":"Zhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"issue":"4","key":"2268_CR1","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.2006070756","volume":"18","author":"T Ali","year":"2007","unstructured":"Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, MacLeod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292\u20138. https:\/\/doi.org\/10.1681\/ASN.2006070756.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2268_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.7326\/0003-4819-86-6-803","volume":"86","author":"M Rozencweig","year":"1977","unstructured":"Rozencweig M, von Hoff DD, Slavik M, Muggia FM. Cis-diamminedichloroplatinum (II). A new anticancer drug. Ann Intern Med. 1977;86(6):803\u201312. https:\/\/doi.org\/10.7326\/0003-4819-86-6-803.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2268_CR3","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1634\/stemcells.2007-0795","volume":"26","author":"M Morigi","year":"2008","unstructured":"Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells. 2008;26(8):2075\u201382. https:\/\/doi.org\/10.1634\/stemcells.2007-0795.","journal-title":"Stem Cells"},{"issue":"3","key":"2268_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/stem.293","volume":"28","author":"M Morigi","year":"2010","unstructured":"Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, Rebulla P, Introna M, Capelli C, Benigni A, Remuzzi G, Lazzari L. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells. 2010;28(3):513\u201322. https:\/\/doi.org\/10.1002\/stem.293.","journal-title":"Stem Cells"},{"issue":"7","key":"2268_CR5","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","volume":"15","author":"M Morigi","year":"2004","unstructured":"Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15(7):1794\u2013804. https:\/\/doi.org\/10.1097\/01.ASN.0000128974.07460.34.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2268_CR6","first-page":"207","volume":"4","author":"M Nafar","year":"2010","unstructured":"Nafar M, Parvin M, Sadeghi P, Ghoraishian M, Soleimani M, Tabibi A, Nouralizadeh A, Amirkhanlou S, Barzi F, Alipour B. Effects of stem cells and granulocyte colony stimulating factor in reperfusion injury. Iran J Kidney Dis. 2010;4(3):207\u201313.","journal-title":"Iran J Kidney Dis"},{"issue":"1-2","key":"2268_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000337595","volume":"29","author":"BV Nogueira","year":"2012","unstructured":"Nogueira BV, Palomino Z, Porto ML, Balarini CM, Pereira TM, Baldo MP, et al. Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension. Cell Physiol Biochem. 2012;29(1-2):143\u201352. https:\/\/doi.org\/10.1159\/000337595.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2268_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2369-13-105","volume":"13","author":"X Jia","year":"2012","unstructured":"Jia X, Xie X, Feng G, Lu H, Zhao Q, Che Y, et al. Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury. BMC Nephrol. 2012;13(1):105. https:\/\/doi.org\/10.1186\/1471-2369-13-105.","journal-title":"BMC Nephrol"},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"204020661982938","DOI":"10.1177\/2040206619829382","volume":"27","author":"E De Clercq","year":"2019","unstructured":"De Clercq E. Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. Antiviral Chem Chemotherapy. 2019;27:2040206619829382.","journal-title":"Antiviral Chem Chemotherapy"},{"key":"2268_CR10","doi-asserted-by":"publisher","unstructured":"Zuk, A, Gershenovich, M, Ivanova, Y, MacFarland, RT, Fricker, SP, and Ledbetter, SR. CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Renal Physiol. 2014;307(7):F783\u201397. https:\/\/doi.org\/10.1152\/ajprenal.00685.2013.","DOI":"10.1152\/ajprenal.00685.2013"},{"issue":"24","key":"2268_CR11","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.0914248107","volume":"107","author":"K Jujo","year":"2010","unstructured":"Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E, Kobayashi K, Tongers J, Roncalli J, Tsurumi Y, Hagiwara N, Losordo DW. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A. 2010;107(24):11008\u201313. https:\/\/doi.org\/10.1073\/pnas.0914248107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2268_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092227","volume":"9","author":"LH Chen","year":"2014","unstructured":"Chen LH, Advani SL, Thai K, Kabir MG, Sood MM, Gibson IW, Yuen DA, Connelly KA, Marsden PA, Kelly DJ, Gilbert RE, Advani A. SDF-1\/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease. PLoS One. 2014;9(3):e92227. https:\/\/doi.org\/10.1371\/journal.pone.0092227.","journal-title":"PLoS One"},{"issue":"2","key":"2268_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149926","volume":"11","author":"J Yang","year":"2016","unstructured":"Yang J, Zhu F, Wang X, Yao W, Wang M, Pei G, Hu Z, Guo Y, Zhao Z, Wang P, Mou J, Sun J, Zeng R, Xu G, Liao W, Yao Y. Continuous AMD3100 treatment worsens renal fibrosis through regulation of bone marrow derived pro-angiogenic cells homing and T-cell-related inflammation. PLoS One. 2016;11(2):e0149926. https:\/\/doi.org\/10.1371\/journal.pone.0149926.","journal-title":"PLoS One"},{"issue":"3","key":"2268_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.scr.2011.05.003","volume":"7","author":"HD Theiss","year":"2011","unstructured":"Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, Brunner S, Vanchev Y, Fischer R, Gr\u00f6bner M, Huber B, Wollenweber T, Assmann G, Mueller-Hoecker J, Hacker M, Franz WM. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1\/CXCR4 axis. Stem Cell Res. 2011;7(3):244\u201355. https:\/\/doi.org\/10.1016\/j.scr.2011.05.003.","journal-title":"Stem Cell Res"},{"issue":"7","key":"2268_CR15","doi-asserted-by":"publisher","first-page":"F783","DOI":"10.1152\/ajprenal.00685.2013","volume":"307","author":"A Zuk","year":"2014","unstructured":"Zuk A, Gershenovich M, Ivanova Y, MacFarland RT, Fricker SP, Ledbetter S. CXCR (4) antagonism as a therapeutic approach to prevent acute kidney injury. Am J Physiol Renal Physiol. 2014;307(7):F783\u201397. https:\/\/doi.org\/10.1152\/ajprenal.00685.2013.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2268_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.stem.2008.10.017","volume":"4","author":"SC Pitchford","year":"2009","unstructured":"Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009;4(1):62\u201372. https:\/\/doi.org\/10.1016\/j.stem.2008.10.017.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"2268_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.bcp.2008.12.014","volume":"77","author":"E De Clercq","year":"2009","unstructured":"De Clercq E. The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol. 2009;77(11):1655\u201364. https:\/\/doi.org\/10.1016\/j.bcp.2008.12.014.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"2268_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1172\/JCI0215623","volume":"110","author":"VY Melnikov","year":"2002","unstructured":"Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest. 2002;110(8):1083\u201391. https:\/\/doi.org\/10.1172\/JCI0215623.","journal-title":"J Clin Invest"},{"issue":"7","key":"2268_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/jir.2013.0077","volume":"34","author":"H Luan","year":"2014","unstructured":"Luan H, Zhang Q, Wang L, Wang C, Zhang M, Xu X, Zhou H, Li X, Xu Q, He F, Yuan J, Lv Y. OM85-BV induced the productions of IL-1\u03b2, IL-6, and TNF-\u03b1 via TLR4- and TLR2-mediated ERK1\/2\/NF-\u03baB pathway in RAW264.7 cells. J Interferon Cytokine Res. 2014;34(7):526\u201336. https:\/\/doi.org\/10.1089\/jir.2013.0077.","journal-title":"J Interferon Cytokine Res"},{"key":"2268_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods (San Diego, Calif). 2001;25:402\u20138.","journal-title":"Methods (San Diego, Calif)"},{"issue":"6","key":"2268_CR21","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00671.2009","volume":"299","author":"N Eliopoulos","year":"2010","unstructured":"Eliopoulos N, Zhao J, Bouchentouf M, Forner K, Birman E, Yuan S, Boivin MN, Martineau D. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am J Physiol Renal Physiol. 2010;299(6):F1288\u201398. https:\/\/doi.org\/10.1152\/ajprenal.00671.2009.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2268_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1681\/ASN.2004010067","volume":"16","author":"M Iwasaki","year":"2005","unstructured":"Iwasaki M, Adachi Y, Minamino K, Suzuki Y, Zhang Y, Okigaki M, Nakano K, Koike Y, Wang J, Mukaide H, Taketani S, Mori Y, Takahashi H, Iwasaka T, Ikehara S. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol. 2005;16(3):658\u201366. https:\/\/doi.org\/10.1681\/ASN.2004010067.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2268_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ultrasmedbio.2015.10.005","volume":"42","author":"G Wang","year":"2016","unstructured":"Wang G, Zhang Q, Zhuo Z, Wu S, Xu Y, Zou L, Gan L, Tan K, Xia H, Liu Z, Gao Y. Enhanced homing of CXCR-4 modified bone marrow-derived mesenchymal stem cells to acute kidney injury tissues by micro-bubble-mediated ultrasound exposure. Ultrasound Med Biol. 2016;42(2):539\u201348. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2015.10.005.","journal-title":"Ultrasound Med Biol"},{"issue":"5","key":"2268_CR24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1182\/blood-2005-02-0468","volume":"106","author":"N Flomenberg","year":"2005","unstructured":"Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005;106(5):1867\u201374. https:\/\/doi.org\/10.1182\/blood-2005-02-0468.","journal-title":"Blood"},{"issue":"8","key":"2268_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3109\/14653240903121245","volume":"11","author":"S Fruehauf","year":"2009","unstructured":"Fruehauf S, Veldwijk MR, Seeger T, Schubert M, Laufs S, Topaly J, Wuchter P, Dillmann F, Eckstein V, Wenz F, Goldschmidt H, Ho AD, Calandra G. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Cytotherapy. 2009;11(8):992\u20131001. https:\/\/doi.org\/10.3109\/14653240903121245.","journal-title":"Cytotherapy"},{"issue":"8","key":"2268_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1084\/jem.20041385","volume":"201","author":"HE Broxmeyer","year":"2005","unstructured":"Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, Calandra G, Bridger G, Dale DC, Srour EF. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201(8):1307\u201318. https:\/\/doi.org\/10.1084\/jem.20041385.","journal-title":"J Exp Med"},{"issue":"23","key":"2268_CR27","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","volume":"113","author":"JF DiPersio","year":"2009","unstructured":"DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood. 2009;113(23):5720\u20136. https:\/\/doi.org\/10.1182\/blood-2008-08-174946.","journal-title":"Blood"},{"issue":"28","key":"2268_CR28","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","volume":"27","author":"JF DiPersio","year":"2009","unstructured":"DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G, 3101 Investigators. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2009;27(28):4767\u201373. https:\/\/doi.org\/10.1200\/JCO.2008.20.7209.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2268_CR29","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1182\/blood-2006-04-013755","volume":"108","author":"BJ Capoccia","year":"2006","unstructured":"Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood. 2006;108(7):2438\u201345. https:\/\/doi.org\/10.1182\/blood-2006-04-013755.","journal-title":"Blood"},{"issue":"3","key":"2268_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1537-2995.2005.04222.x","volume":"45","author":"WC Liles","year":"2005","unstructured":"Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G, Christensen J, Wood B, Price TH, Dale DC. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion. 2005;45(3):295\u2013300. https:\/\/doi.org\/10.1111\/j.1537-2995.2005.04222.x.","journal-title":"Transfusion"},{"issue":"12","key":"2268_CR31","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1182\/blood-2006-06-030577","volume":"108","author":"RM Shepherd","year":"2006","unstructured":"Shepherd RM, Capoccia BJ, Devine SM, Dipersio J, Trinkaus KM, Ingram D, et al. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood. 2006;108(12):3662\u20137. https:\/\/doi.org\/10.1182\/blood-2006-06-030577.","journal-title":"Blood"},{"issue":"4","key":"2268_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/kisup.2013.78","volume":"3","author":"ME Rosenberg","year":"2013","unstructured":"Rosenberg ME. Cell-based therapies in kidney disease. Kidney Int Supplements. 2013;3(4):364\u20137. https:\/\/doi.org\/10.1038\/kisup.2013.78.","journal-title":"Kidney Int Supplements"},{"issue":"9","key":"2268_CR33","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1681\/ASN.2007020140","volume":"18","author":"B Bi","year":"2007","unstructured":"Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007;18(9):2486\u201396. https:\/\/doi.org\/10.1681\/ASN.2007020140.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2268_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1479-5876-9-51","volume":"9","author":"YT Chen","year":"2011","unstructured":"Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, Tsai TH, Chung SY, Chua S, Kao YH, Yen CH, Shao PL, Chang KC, Leu S, Yip HK. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 2011;9(1):51. https:\/\/doi.org\/10.1186\/1479-5876-9-51.","journal-title":"J Transl Med"},{"issue":"6","key":"2268_CR35","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3892\/ijmm.2013.1517","volume":"32","author":"S Qi","year":"2013","unstructured":"Qi S, Wu D. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis. Int J Mol Med. 2013;32(6):1262\u201372. https:\/\/doi.org\/10.3892\/ijmm.2013.1517.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2268_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1479-5876-10-243","volume":"10","author":"MS Masoud","year":"2012","unstructured":"Masoud MS, Anwar SS, Afzal MZ, Mehmood A, Khan SN, Riazuddin S. Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. J Transl Med. 2012;10(1):243. https:\/\/doi.org\/10.1186\/1479-5876-10-243.","journal-title":"J Transl Med"},{"issue":"4","key":"2268_CR37","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815\u201322. https:\/\/doi.org\/10.1182\/blood-2004-04-1559.","journal-title":"Blood"},{"key":"2268_CR38","doi-asserted-by":"publisher","first-page":"392050","DOI":"10.1155\/2012\/392050","volume":"2012","author":"JM Milwid","year":"2012","unstructured":"Milwid JM, Ichimura T, Li M, Jiao Y, Lee J, Yarmush JS, et al. Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells Int. 2012;2012:392050.","journal-title":"Stem Cells Int"},{"issue":"3","key":"2268_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6","volume":"166","author":"SE Haynesworth","year":"1996","unstructured":"Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol. 1996;166(3):585\u201392. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2268_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.107.119792","volume":"322","author":"S Faubel","year":"2007","unstructured":"Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, Oh DJ, Lu L, Klein CL, Dinarello CA, Edelstein CL. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1\u03b2, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther. 2007;322(1):8\u201315. https:\/\/doi.org\/10.1124\/jpet.107.119792.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2268_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1172\/JCI200215606","volume":"110","author":"G Ramesh","year":"2002","unstructured":"Ramesh G, Reeves WB. TNF-\u03b1 mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110(6):835\u201342. https:\/\/doi.org\/10.1172\/JCI200215606.","journal-title":"J Clin Invest"},{"issue":"2","key":"2268_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yexcr.2016.03.002","volume":"342","author":"JM Overath","year":"2016","unstructured":"Overath JM, Gauer S, Obermuller N, Schubert R, Schafer R, Geiger H, et al. Short-term preconditioning enhances the therapeutic potential of adipose-derived stromal\/stem cell-conditioned medium in cisplatin-induced acute kidney injury. Exp Cell Res. 2016;342(2):175\u201383. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.002.","journal-title":"Exp Cell Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-021-02268-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02268-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T16:15:34Z","timestamp":1616602534000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02268-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02268-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-152800\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed using C57BL\/6J mice and were conducted according to the Huazhong University of Science and Technology Guide for the Care and Use of Laboratory Animals. All experimental animal procedures were approved by the Institutional Animal Care and Use Committee of Huazhong University of Science and Technology, Wuhan, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}